U.S. Corporations Face Reckoning Over Prescription Opioids, CEOs Keep Cashing In Companies that sold or distributed opioid medications face...
U.S. Corporations Face Reckoning Over Prescription Opioids, CEOs Keep Cashing In
Companies that sold or distributed opioid medications face huge legal, financial and public relations peril. Critics say shareholders, not CEOs, will pay the price.
Read more on NPR
Companies that sold or distributed opioid medications face huge legal, financial and public relations peril. Critics say shareholders, not CEOs, will pay the price.
Read more on NPR
